Transfer of medical and pharmaceutical technologies: meeting

Recently, Sechenov University hosted a meeting on the formation of the National Centre for Transfer of Medical and Pharmaceutical Technologies. Sechenov University initiated the creation of this organisation.

At the opening of the event, Vadim Tarasov, Director of the Institute for Translational Medicine and Biotechnology at Sechenov University, spoke about the importance of unification for transferring medical and pharmaceutical technologies.

“Creation of complex products is the result of collaborations between large teams and organisations — and the result of building partnerships between researchers, investors, and industry,” said Vadim Tarasov.

Translation from research to large industry projects in the Russian healthcare is in line with one of the three strategic projects of Sechenov University within the development programme aligned with the federal project “Priority 2030”.

According to Andrey Svistunov, First Vice-Rector of Sechenov University, the strategic project will lead to a completely new system for the development and testing of medical products, with a full cycle of translational research based on international standards.

“As a result, a missing link will be created in our country for bringing our achievements to the global market of pharmaceutical and biomedical technologies and products. We are talking about medications for the treatment of cancer, hereditary and autoimmune diseases,” stressed Andrey Svistunov.

Technology transfer experts say that the most relevant areas, apart from pharmaceuticals, are telemedicine and digital health. At the same time, the trust between patients and doctors remains important. The patient’s health and adherence to therapy directly depend on the level of trust.

The meeting at Sechenov University was attended by representatives of the National Association for Technology Transfer, Institute for Intellectual Property Security, Association of Innovation and Technology Brokers, ITMO University, JSC “Rusatom Healthcare”, State Corporation “Rostec”, JSC “SOGAZ”, INVITRO, and universities that are members of the Consortium for Transfer of Medical and Pharmaceutical Technologies (includes Sechenov University, Kuban State Medical University, Saratov State Medical University, Siberian State Medical University, and Mendeleev University of Chemical Technology).